Indicating their origin from S100A9 MDSCs, it was also found that the percentage of blood S100A9 MDSCs was closely correlated with the counts of S100A9 cells and CD68 TAM in tumor tissue, and patients with higher S100A9 and CD68 cell numbers also showed worse PFS (57). This evidence concerns the gene S100A9 and neoplasm.